Distinctive alterations in the mesocorticolimbic circuits in various psychiatric disorders

Psychiatry Clin Neurosci. 2023 Jun;77(6):345-354. doi: 10.1111/pcn.13542. Epub 2023 Mar 30.

Abstract

Aim: Increasing evidence suggests that psychiatric disorders are linked to alterations in the mesocorticolimbic dopamine-related circuits. However, the common and disease-specific alterations remain to be examined in schizophrenia (SCZ), major depressive disorder (MDD), and autism spectrum disorder (ASD). Thus, this study aimed to examine common and disease-specific features related to mesocorticolimbic circuits.

Methods: This study included 555 participants from four institutes with five scanners: 140 individuals with SCZ (45.0% female), 127 individuals with MDD (44.9%), 119 individuals with ASD (15.1%), and 169 healthy controls (HC) (34.9%). All participants underwent resting-state functional magnetic resonance imaging. A parametric empirical Bayes approach was adopted to compare estimated effective connectivity among groups. Intrinsic effective connectivity focusing on the mesocorticolimbic dopamine-related circuits including the ventral tegmental area (VTA), shell and core parts of the nucleus accumbens (NAc), and medial prefrontal cortex (mPFC) were examined using a dynamic causal modeling analysis across these psychiatric disorders.

Results: The excitatory shell-to-core connectivity was greater in all patients than in the HC group. The inhibitory shell-to-VTA and shell-to-mPFC connectivities were greater in the ASD group than in the HC, MDD, and SCZ groups. Furthermore, the VTA-to-core and VTA-to-shell connectivities were excitatory in the ASD group, while those connections were inhibitory in the HC, MDD, and SCZ groups.

Conclusion: Impaired signaling in the mesocorticolimbic dopamine-related circuits could be an underlying neuropathogenesis of various psychiatric disorders. These findings will improve the understanding of unique neural alternations of each disorder and will facilitate identification of effective therapeutic targets.

Keywords: autism spectrum disorder; dynamic causal modeling; major depressive disorder; mesocorticolimbic circuits; schizophrenia.

MeSH terms

  • Autism Spectrum Disorder*
  • Bayes Theorem
  • Depressive Disorder, Major* / diagnostic imaging
  • Dopamine
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Mental Disorders* / diagnostic imaging
  • Neural Pathways / diagnostic imaging
  • Prefrontal Cortex / diagnostic imaging

Substances

  • Dopamine